166 related articles for article (PubMed ID: 30950204)
1. Prognostic implications of a molecular classifier derived from whole-exome sequencing in nasopharyngeal carcinoma.
Wang HY; Li F; Liu N; Liu XY; Yang XH; Guo YM; Bei JX; Zeng YX; Shao JY
Cancer Med; 2019 Jun; 8(6):2705-2716. PubMed ID: 30950204
[TBL] [Abstract][Full Text] [Related]
2. Whole exome sequencing and transcriptome-wide profiling identify potentially subtype-relevant genes of nasopharyngeal carcinoma.
Liu J; Li X; Yang S; Mou J; Lu H
Pathol Res Pract; 2020 Dec; 216(12):153244. PubMed ID: 33113455
[TBL] [Abstract][Full Text] [Related]
3. Whole-Exome Sequencing of Nasopharyngeal Carcinoma Families Reveals Novel Variants Potentially Involved in Nasopharyngeal Carcinoma.
Yu G; Hsu WL; Coghill AE; Yu KJ; Wang CP; Lou PJ; Liu Z; Jones K; Vogt A; Wang M; Mbulaiteye SM; Chen HH; Boland J; Yeager M; Diehl SR; Chen CJ; Hildesheim A; Goldstein AM
Sci Rep; 2019 Jul; 9(1):9916. PubMed ID: 31289279
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study.
Tang XR; Li YQ; Liang SB; Jiang W; Liu F; Ge WX; Tang LL; Mao YP; He QM; Yang XJ; Zhang Y; Wen X; Zhang J; Wang YQ; Zhang PP; Sun Y; Yun JP; Zeng J; Li L; Liu LZ; Liu N; Ma J
Lancet Oncol; 2018 Mar; 19(3):382-393. PubMed ID: 29428165
[TBL] [Abstract][Full Text] [Related]
5. Targeted sequencing of cancer-related genes in nasopharyngeal carcinoma identifies mutations in the TGF-β pathway.
Chung AK; OuYang CN; Liu H; Chao M; Luo JD; Lee CY; Lu YJ; Chung IC; Chen LC; Wu SM; Tsang NM; Chang KP; Hsu CL; Li HP; Chang YS
Cancer Med; 2019 Sep; 8(11):5116-5127. PubMed ID: 31328403
[TBL] [Abstract][Full Text] [Related]
6. Secreted protein acidic and rich in cysteine (SPARC) is associated with nasopharyngeal carcinoma metastasis and poor prognosis.
Wang HY; Li YY; Shao Q; Hou JH; Wang F; Cai MB; Zeng YX; Shao JY
J Transl Med; 2012 Feb; 10():27. PubMed ID: 22321704
[TBL] [Abstract][Full Text] [Related]
7. Integrated genomic analyses in PDX model reveal a cyclin-dependent kinase inhibitor Palbociclib as a novel candidate drug for nasopharyngeal carcinoma.
Hsu CL; Lui KW; Chi LM; Kuo YC; Chao YK; Yeh CN; Lee LY; Huang Y; Lin TL; Huang MY; Lai YR; Yeh YM; Fan HC; Lin AC; Lu YJ; Hsieh CH; Chang KP; Tsang NM; Wang HM; Chang AY; Chang YS; Li HP
J Exp Clin Cancer Res; 2018 Sep; 37(1):233. PubMed ID: 30236142
[TBL] [Abstract][Full Text] [Related]
8. Prognostic nomogram for patients with Nasopharyngeal Carcinoma incorporating hematological biomarkers and clinical characteristics.
Li J; Chen S; Peng S; Liu Y; Xing S; He X; Chen H
Int J Biol Sci; 2018; 14(5):549-556. PubMed ID: 29805306
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival.
Dubot C; Bernard V; Sablin MP; Vacher S; Chemlali W; Schnitzler A; Pierron G; Ait Rais K; Bessoltane N; Jeannot E; Klijanienko J; Mariani O; Jouffroy T; Calugaru V; Hoffmann C; Lesnik M; Badois N; Berger F; Le Tourneau C; Kamal M; Bieche I
Eur J Cancer; 2018 Mar; 91():47-55. PubMed ID: 29331751
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of cyclin D1 can act as an independent prognostic marker for longer survival time in human nasopharyngeal carcinoma.
Liu Y; Liu Q; Wang Z; Chen M; Chen Y; Li X; Huang D; Fan S; Xiong W; Li G; Zhang W
J Clin Lab Anal; 2020 Aug; 34(8):e23298. PubMed ID: 32697404
[TBL] [Abstract][Full Text] [Related]
11. Prognostic values of the integrated model incorporating the volume of metastatic regional cervical lymph node and pretreatment serum Epstein-Barr virus DNA copy number in predicting distant metastasis in patients with N1 nasopharyngeal carcinoma.
Yao JJ; Zhou GQ; Wang YQ; Wang SY; Zhang WJ; Jin YN; Zhang F; Li L; Liu LZ; Cheng ZB; Ma J; Qi ZY; Sun Y
Chin J Cancer; 2017 Dec; 36(1):98. PubMed ID: 29284539
[TBL] [Abstract][Full Text] [Related]
12. A novel prognostic model predicts overall survival in patients with nasopharyngeal carcinoma based on clinical features and blood biomarkers.
Lai C; Zhang C; Lv H; Huang H; Ke X; Zhou C; Chen H; Chen S; Zhou L
Cancer Med; 2021 Jun; 10(11):3511-3523. PubMed ID: 33973727
[TBL] [Abstract][Full Text] [Related]
13. Functional Polymorphisms and Gene Expression of TLR9 Gene as Protective Factors for Nasopharyngeal Carcinoma Severity and Progression.
Yosra M; Sameh S; Randa G; Yassmine R; Sallouha G; Nadia B; Noureddine B; Abdelfattah Z; Elham H
J Immunol Res; 2019; 2019():2826563. PubMed ID: 31886298
[TBL] [Abstract][Full Text] [Related]
14. Anti-epidermal growth factor receptor monoclonal antibody plus palliative chemotherapy as a first-line treatment for recurrent or metastatic nasopharyngeal carcinoma.
Chen C; Zhou Y; Zhang X; Fu S; Lin Z; Fang W; Yang Y; Huang Y; Zhao H; Hong S; Zhang L
Cancer Med; 2020 Mar; 9(5):1721-1732. PubMed ID: 31955525
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive genomic profiling of different subtypes of nasopharyngeal carcinoma reveals similarities and differences to guide targeted therapy.
Ali SM; Yao M; Yao J; Wang J; Cheng Y; Schrock AB; Chirn GW; Chen H; Mu S; Gay L; Elvin JA; Suh J; Miller VA; Stephens PJ; Ross JS; Wang K
Cancer; 2017 Sep; 123(18):3628-3637. PubMed ID: 28581676
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of lncRNA SNHG12 predicts a poor prognosis of nasopharyngeal carcinoma and regulates cell proliferation and metastasis by modulating Notch signal pathway.
Liu ZB; Tang C; Jin X; Liu SH; Pi W
Cancer Biomark; 2018; 23(4):603-613. PubMed ID: 30452404
[TBL] [Abstract][Full Text] [Related]
17. Association of Intratumoral Microbiota With Prognosis in Patients With Nasopharyngeal Carcinoma From 2 Hospitals in China.
Qiao H; Tan XR; Li H; Li JY; Chen XZ; Li YQ; Li WF; Tang LL; Zhou GQ; Zhang Y; Liang YL; He QM; Zhao Y; Huang SY; Gong S; Li Q; Ye ML; Chen KL; Sun Y; Ma J; Liu N
JAMA Oncol; 2022 Sep; 8(9):1301-1309. PubMed ID: 35834269
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis.
Liu N; Chen NY; Cui RX; Li WF; Li Y; Wei RR; Zhang MY; Sun Y; Huang BJ; Chen M; He QM; Jiang N; Chen L; Cho WC; Yun JP; Zeng J; Liu LZ; Li L; Guo Y; Wang HY; Ma J
Lancet Oncol; 2012 Jun; 13(6):633-41. PubMed ID: 22560814
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation biomarkers for nasopharyngeal carcinoma.
Han B; Yang X; Zhang P; Zhang Y; Tu Y; He Z; Li Y; Yuan J; Dong Y; Hosseini DK; Zhou T; Sun H
PLoS One; 2020; 15(4):e0230524. PubMed ID: 32271791
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive Genomic Analysis of Translocation Renal Cell Carcinoma Reveals Copy-Number Variations as Drivers of Disease Progression.
Marcon J; DiNatale RG; Sanchez A; Kotecha RR; Gupta S; Kuo F; Makarov V; Sandhu A; Mano R; Silagy AW; Blum KA; Nassau DE; Benfante NE; Ortiz MV; Carlo MI; Chan TA; Motzer RJ; Voss MH; Coleman J; Russo P; Reuter V; Hakimi AA; Reznik E
Clin Cancer Res; 2020 Jul; 26(14):3629-3640. PubMed ID: 32220885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
